4//SEC Filing
Freedberg Jared 4
Accession 0001104659-21-010364
CIK 0001270073other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 7:02 PM ET
Size
7.8 KB
Accession
0001104659-21-010364
Insider Transaction Report
Form 4
Freedberg Jared
General Counsel and Secretary
Transactions
- Award
Option to Purchase Common Stock
2021-02-01+69,400→ 69,400 totalExercise: $36.90Exp: 2031-02-01→ Common Stock (69,400 underlying) - Award
Common Stock
2021-02-01+44,277→ 44,277 total
Footnotes (2)
- [F1]Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and the remaining shares vesting pro rata on each subsequent three-month anniversary of the Vesting Commencement Date. The Vesting Commencement Date is February 1, 2021.
- [F2]The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is February 1, 2021.
Documents
Issuer
INTERCEPT PHARMACEUTICALS, INC.
CIK 0001270073
Entity typeother
Related Parties
1- filerCIK 0001754157
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 7:02 PM ET
- Size
- 7.8 KB